Stock listing
XERS Stock Price, News, Filings & Events — Xeris Biopharma Holdings, Inc.
Selected listing: XERS · BOATS · USD · US
This page tracks Xeris Biopharma Holdings, Inc.'s XERS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XERS:BOATS. XERS:BOATS is the stock-level entry point for investors researching Xeris Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xeris Biopharma Holdings, Inc. is a public company traded under the ticker XERS in the American market. The company has a market capitalization of approximately $1.44 billion. Xeris focuses on developing and commercializing innovative therapeutics to improve patient outcomes.
- Ticker
- XERS:BOATS
- Asset type
- Stock
- Market cap
- $1.56B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Xeris Biopharma Holdings, Inc. XERS:BOATS stock context
This page tracks Xeris Biopharma Holdings, Inc.'s XERS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XERS:BOATS. XERS:BOATS is the stock-level entry point for investors researching Xeris Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xeris Biopharma Holdings, Inc. is a public company traded under the ticker XERS in the American market. The company has a market capitalization of approximately $1.44 billion. Xeris focuses on developing and commercializing innovative therapeutics to improve patient outcomes.
Latest news from Xeris Biopharma Holdings, Inc.
medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector
September 10, 2026
Medmix : rsquo; Drug Delivery (“Haselmeier”) to support the development of Xeris Pharmaceuticals’ XP-8121 with D-Flex™ pen injector
September 10, 2026
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxi...
September 9, 2026
Xeris Announces Details for XP-8121 Program Overview Webinar
August 26, 2026
Xeris Biopharma : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Xeris Biopharma Holdings, Inc. earnings calls
Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call
March 2, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. investor report
Review AI stock analysis and investor report context for XERS:BOATS.
Xeris Biopharma Holdings, Inc. company profile
View the public company page for Xeris Biopharma Holdings, Inc. on 6ix.
Xeris Biopharma Holdings, Inc. news
Read company news and market updates connected to Xeris Biopharma Holdings, Inc..
Xeris Biopharma Holdings, Inc. investor events
Find investor webinars, events, and replay context for Xeris Biopharma Holdings, Inc..
Alternate listings
XERS:NASDAQ
US · USD
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
A3C4ZC:LSX
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:TRADEGATE
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
A3C4ZC:LS
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B3:FWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:GETTEX
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
0A8E:LSE
GB · USD
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:DUS
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:FWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:MUN
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.
2B30:SWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is XERS:BOATS.